卵巢子宫内膜异位囊肿自然进展的超声研究
本研究为回顾性队列研究,纳入83例期待管理的卵巢子宫内膜异位囊肿女性,至少两次由同一专家行超声检查,间隔≥6个月。中位随访634天,39/83(47%)囊肿缩小,18/83(22%)增大,26/83(31%)无显著变化;中位年均消退率-1.7 mm/年/人,随访时囊肿中位直径显著小于初诊(18.5 mm vs 22.3 mm,P=0.009)。作者认为多数囊肿不显著增大,可期待管理。
要点
- 期待管理的卵巢子宫内膜异位囊肿中,47%缩小、22%增大、31%无显著变化。
- 随访时囊肿中位直径18.5 mm显著小于初诊22.3 mm(P=0.009)。
- 未发现可可靠预测囊肿进展的临床特征。
核心结论
- 多数超声诊断的卵巢子宫内膜异位囊肿随时间不显著增大,可期待管理。
- 该证据可能有助于临床医生为无症状或轻微症状女性提供咨询。
研究设计与样本
- 回顾性队列研究,纳入2007年4月至2022年5月期间在伦敦大学学院医院女性健康部和伦敦妇科超声中心期待管理≥6个月的83例卵巢子宫内膜异位囊肿女性。
- 所有女性至少接受两次由同一专家超声操作者完成的超声检查,间隔至少≥6个月。
- 记录囊肿数量、平均直径和位置,囊肿增长率以平均直径的年变化表示。
主要发现
- 研究期间妇科门诊共1922例女性经盆腔超声发现中或重度子宫内膜异位症,其中83例有卵巢子宫内膜异位囊肿并期待管理。
- 初诊中位年龄39岁(范围26-51岁),每例患者子宫内膜异位囊肿中位数1个(范围1-5个),中位随访634天(范围187-2984天)。
- 83例中50例(60%,95%CI 49-71%)为单发囊肿,其余为多发囊肿。
- 39/83(47%,95%CI 36-58%)囊肿整体缩小,18/83(22%,95%CI 13-32%)增大,26/83(31%,95%CI 22-42%)无有意义变化。
- 每例患者研究期间平均囊肿直径中位变化-2.7 mm(范围-57.7至39.3 mm),中位年消退率-1.7 mm/年/人(范围-24.6至42.0 mm/年/人);与初诊相比,随访时囊肿显著更小(中位直径22.3 mm(范围6.7-77.0 mm) vs 18.5 mm(范围5.0-72.0 mm);P=0.009)。
临床怎么用
- 作者认为多数超声诊断的卵巢子宫内膜异位囊肿不随时间显著增大,可期待管理。
- 作者认为该证据可能有助于临床医生为无症状或轻微症状女性提供咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the natural progression of ovarian endometrioma in women who are managed expectantly. METHODS: This was a retrospective cohort study of 83 women with evidence of ovarian endometrioma who were managed expectantly between April 2007 and May 2022. The study was conducted in the Department of Women's Health, University College London Hospitals and The Gynecology Ultrasound Centre, London, UK. We searched our ultrasound clinic databases to identify women aged 18 years or older with evidence of ovarian endometrioma who were managed expectantly for ≥ 6 months. All women attended for a minimum of two ultrasound scans performed by a single expert ultrasound operator. In addition to patient demographics, we recorded the number, mean diameter and location of each cyst. The cyst growth rate was expressed as annual change in the mean diameter. RESULTS: A total of 1922 women who attended our gynecology clinic during the study period were found to have evidence of moderate or severe endometriosis on pelvic ultrasound examination. Of those, 83 women had evidence of ovarian endometrioma and were managed expectantly. The median age of women was 39 (range, 26-51) years at the initial visit. Each woman had at least two ultrasound scans performed by a single expert operator at a minimum interval of ≥ 6 months. Of 83 women diagnosed with endometrioma, 50 (60% (95% CI, 49-71%)) had a single cyst and the remainder had multiple cysts. The median number of endometriomas per patient was 1 (range, 1-5) and the median follow-up time was 634 (range, 187-2984) days. A total of 39/83 (47% (95% CI, 36-58%)) women experienced an overall reduction in size of cysts, in 18/83 (22% (95% CI, 13-32%)) the cysts increased in size and in 26/83 (31% (95% CI, 22-42%)) women, no meaningful change in size was observed. The median change in mean cyst diameter per woman during the study period was -2.7 (range, -57.7 to 39.3) mm, with a median annual regression rate of -1.7 (range, -24.6 to 42.0) mm/year/woman. Overall, when compared with the initial visit, cysts were significantly smaller at follow-up (median diameter, 22.3 (range, 6.7-77.0) mm vs 18.5 (range, 5.0-72.0) mm; P = 0.009). We did not identify any clinical characteristics that could reliably predict the chance of endometrioma progression. CONCLUSIONS: In the majority of women with an ultrasound diagnosis of ovarian endometrioma, the cysts do not increase in size significantly over time and they could be managed expectantly. This evidence may help clinicians when counseling asymptomatic or minimally symptomatic women about management of ovarian endometrioma. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Knez J, Bean E, Nijjar S, et al. Ultrasound study of natural progression of ovarian endometrioma. Ultrasound Obstet Gynecol. 2024. PMID: 38337178. doi:10.1002/uog.27607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。